Please login to the form below
Novatis
This page shows the latest Novatis news and features for those working in and with pharma, biotech and healthcare.
Novartis sales dip, but all eyes are on Entresto
Newheart failure drug could return the company to growth
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Experienced Editor, London, Medical Communications
-
Competitive package
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Scientific Team Lead
-
Competitive Salary
-
Account Director
-
Negotiable
- Director Healthcare PR Communications
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
-
Scientific Director
-
Highly Competitive Salary &Benefits
-
Account Director - Digital
-
Great salary and benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Account Director – Global Healthcare PR
-
Salary TBC
- Account Manager, Healthcare Advertising
-
Salary TBC
Subscribe to our email news alerts
- AcelRX’s potent opioid tablets set to win FDA backing for pain relief
- New leader at Medivir after setbacks
- Roche preps new Kadcyla filings after phase 3 trial win
- Porterhouse Medical Group boosts its scientific services team with two new appointments
- Redefining communications excellence
- AstraZeneca: building a new ‘open innovation’ pharma company
PMHub
Novasecta
We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...
Latest intelligence
- Redefining communications excellence
- How to be heard in today’s multichannel, multistakeholder, multimedia world...
- AstraZeneca: building a new ‘open innovation’ pharma company
- The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
- In conversation with Pfizer’s Erik Nordkamp
- Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...
Quick links
Infographics
